Remember to weigh up risks and benefits of new PBS-listed anticoagulants

NPS MedicineWise is reiterating safety messages around the newer anticoagulants dabigatran (Pradaxa) and apixaban (Eliquis) following their PBS listing for preventing stroke on 1 September 2013 - and again for rivaxabaran (Xarelto) which was PBS listed in August for the same purpose. These medicines will be subsidised by the Pharmaceutical Benefits Scheme (PBS) for preventing stroke in people with non-valvular atrial fibrillation, and may offer alternatives for some people...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Stroke Source Type: news